Valentina Fedele
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration.
Journal: British journal of clinical pharmacology
Published: October 02, 2017
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression.
Journal: Medicine
Published: November 19, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen.
Journal: The Journal of antimicrobial chemotherapy
Published: August 03, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro.
Journal: Journal of global antimicrobial resistance
Published: February 05, 2016
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.
Journal: Antimicrobial agents and chemotherapy
Published: January 19, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
Journal: The Journal of antimicrobial chemotherapy
Published: October 28, 2014
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes.
Journal: The Journal of antimicrobial chemotherapy
Published: May 27, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026